Diadenosine P1, P4-tetraphosphate and its tetraphosphonate derivatives synergistically inhibit platelet activation via both P2Y1 and P2Y12

被引:0
|
作者
Chang, Hung
Yanachkov, Ivan B.
Michelson, Alan D.
Li, YouFu
Barnard, Marc R.
Wright, George E.
Frelinger, Andrew L., III
机构
[1] Univ Massachusetts, Sch Med, Ctr Platelet Funct Studies, Worcester, MA 01605 USA
[2] GL Synth, Worcester, MA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A281 / A281
页数:1
相关论文
共 50 条
  • [31] P2Y12 receptor in platelet activation
    Kim, Soochong
    Kunapuli, Satya P.
    PLATELETS, 2011, 22 (01) : 56 - 60
  • [32] T CELL ACTIVATION INVOLVES AUTOCRINE FEEDBACK THROUGH THE ADP RECEPTORS P2Y1, P2Y12, AND P2Y13
    Woehrle, T.
    Ledderose, C.
    Sumi, Y.
    Yip, L.
    Junger, W.
    SHOCK, 2015, 43 (06): : 79 - 80
  • [33] INHIBITION OF ADP-RIBOSYLATION OF HISTONE BY DIADENOSINE 5',5'''-P1,P4-TETRAPHOSPHATE
    TANAKA, Y
    MATSUNAMI, N
    YOSHIHARA, K
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1981, 99 (03) : 837 - 843
  • [34] Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: Role of P2Y1 and P2Y12 receptors.
    Aslam, Muhammad
    Sedding, Daniel
    Koshty, Ahmed
    Santoso, Santot
    Schulz, Rainer
    Hamm, Christian
    Guenduez, Dursun
    THROMBOSIS RESEARCH, 2013, 132 (05) : 548 - 557
  • [35] Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow -: Response
    Turner, NA
    Moake, JL
    McIntire, LV
    BLOOD, 2002, 99 (12) : 4645 - 4646
  • [36] Characterization of the diadenosine 5',5'''-P1,P4-tetraphosphate receptor on equine spermatozoa.
    Schubert, KS
    Henricks, DM
    Hilderman, RH
    Gimenez, T
    Bott, RM
    BIOLOGY OF REPRODUCTION, 1997, 56 : 302 - 302
  • [37] Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets
    Jagroop, IA
    Burnstock, G
    Mikhailidis, DP
    PLATELETS, 2003, 14 (01) : 15 - 20
  • [38] Pharmacodynamic interplay of the P2Y1, P2Y12, and TxA2 pathways in platelets: The potential of triple antiplatelet therapy with P2Y1 receptor antagonism
    Oestreich, Julie H.
    Ferraris, Suellen P.
    Steinhubl, Steven R.
    Akers, Wendell S.
    THROMBOSIS RESEARCH, 2013, 131 (02) : E64 - E70
  • [39] P2Y1 and P2Y12 receptor heterodimerisation: From recombinant systems to native detection
    Safar, M. A.
    Wood, R.
    Cunningham, M. R.
    Kennedy, C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3049 - 3049
  • [40] Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors
    Mamedova, Liaman K.
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (08) : 1031 - 1041